4//SEC Filing
MEDLEY MARK B 4
Accession 0001209191-22-033535
CIK 0001108109other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:31 PM ET
Size
19.4 KB
Accession
0001209191-22-033535
Insider Transaction Report
Form 4
MEDLEY MARK B
Regional President
Transactions
- Tax Payment
Common Stock
2022-06-01$5.00/sh−1,574$7,870→ 58,135 total
Holdings
- 15,000
Stock Options (Right to Buy)
Exercise: $4.93From: 2021-03-01Exp: 2030-02-28→ Common Stock (15,000 underlying) - 25,000
Stock Options (Right to Buy)
Exercise: $10.18From: 2023-03-01Exp: 2032-02-29→ Common Stock (25,000 underlying) - 15,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (15,000 underlying) - 50,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (50,000 underlying) - 15,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (15,000 underlying) - 12,000
Stock Options (Right to Buy)
Exercise: $2.66From: 2020-06-01Exp: 2029-05-31→ Common Stock (12,000 underlying) - 15,000
Stock Options (Right to Buy)
Exercise: $8.81From: 2022-03-01Exp: 2031-02-28→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period.
- [F2]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period.
- [F3]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
- [F4]Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
Issuer
COMMUNITY HEALTH SYSTEMS INC
CIK 0001108109
Entity typeother
Related Parties
1- filerCIK 0001863028
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:31 PM ET
- Size
- 19.4 KB